Pharmaceutical Pricing Strategies 2000 draws upon extensive primary research from over 100 industry executives and regulatory bodies to provide the answers to current and future pricing issues. The report details the changes in pricing regulations in each of the seven major healthcare markets and offers novel analysis as to how they influence the pricing decisions of pharmaceutical players. This report will enable you to assess the direction of future pricing strategies, whilst analyzing the drivers that are likely to reshape the healthcare environment from the increasing power of the patient to the emergence of pharmacoeconomic studies.
